Mucosal inflammation in a genetic model of spontaneous type I diabetes mellitus

被引:19
|
作者
Hardin, JA
Donegan, L
Woodman, RC
Trevenen, C
Gall, DG
机构
[1] Univ Calgary, Fac Med, Gastrointestinal Res Grp, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Fac Med, Immunol Res Grp, Calgary, AB T2N 4N1, Canada
[3] Alberta Childrens Prov Gen Hosp, Calgary, AB T2T 5C7, Canada
关键词
diabetes; inflammation; myeloperoxidase; jejunum;
D O I
10.1139/Y02-138
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The BioBreeding (BB) rat provides a model of spontaneous type I diabetes mellitus that closely resembles the human disease. Diabetes-prone BB rats demonstrate increased intestinal permeability prior to the development of insulinitis. Studies suggest that alterations in intestinal permeability can lead to increased intestinal inflammatory activity. Diabetes-prone (BBdp) and diabetes-resistant (BBdr) BB rats were examined at 45 days and at >70 days of age following the development of clinical disease (BBd). In separate experiments, tissue was assayed for myeloperoxidase (MPO) or fixed for histological assessment and immunohistochemistry. Blood was obtained for leukocyte MPO measurements and morphological assessment of circulating leukocytes. MPO activity was significantly elevated in the distal small intestine of 45-day-old BBdp rats. In contrast, at >70 days of age, MPO activity was significantly increased throughout the small intestine of BBd and non-diabetic BBdp rats. Subsequently, all measurements were performed in >70-day-old rats. An increase in inflammatory infiltrate was noted in the distal small intestine of BBd rats by light microscopy. Infiltrating cells were identified as bands (a maturing cell type of the neutrophil lineage) and mature neutrophils. The findings suggest diabetes susceptibility is associated with an increase in intestinal inflammatory activity.
引用
收藏
页码:1064 / 1070
页数:7
相关论文
共 50 条
  • [31] Canagliflozin use in Type I diabetes mellitus
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2017, 129 (03) : 336 - 339
  • [32] Breast manifestations of type I diabetes mellitus
    Nasser, Haydar A.
    Assaf, Sarah
    Aouad, Ghadir
    Mouawad, Yara
    Elamely, Sabah
    BREAST JOURNAL, 2020, 26 (10): : 2079 - 2080
  • [33] Type I diabetes mellitus and enterovirus infections
    Hober, D
    ANNALES DE BIOLOGIE CLINIQUE, 1997, 55 (03) : 254 - 254
  • [34] Lipoprotein(a) concentrations in diabetes mellitus type I
    Figueroa, AC
    Gil, RL
    Pedragos, AC
    Gonzalez, GC
    Marques, RB
    Diaz, JAA
    Llanos, JO
    Perez, AP
    REVISTA CLINICA ESPANOLA, 1996, 196 (02): : 87 - 91
  • [35] Strategies for preventing type I diabetes mellitus
    Verge, CF
    Eisenbarth, GS
    WESTERN JOURNAL OF MEDICINE, 1996, 164 (03): : 249 - 255
  • [36] Islet transplantation in type I diabetes mellitus
    Gerber, P. A.
    Lehmann, R.
    DIABETOLOGE, 2015, 11 (07): : 545 - 552
  • [37] TYPE-I DIABETES-MELLITUS
    CUDWORTH, AG
    DIABETOLOGIA, 1978, 14 (05) : 281 - 291
  • [38] Coeliac autoimmunity in type I diabetes mellitus
    Joshi, Ameya S.
    Varthakavi, Premlata K.
    Bhagwat, Nikhil M.
    Chadha, Manoj D.
    Mittal, Sachin S.
    ARAB JOURNAL OF GASTROENTEROLOGY, 2014, 15 (02) : 53 - 57
  • [39] Autoimmune Nature of Type I Diabetes Mellitus
    Janvier, Darlyne L.
    Tulp, Orien L.
    Einstein, George P.
    FASEB JOURNAL, 2018, 32 (01):
  • [40] Hearing in Children With Type I Diabetes Mellitus
    Fukuda, Claudia
    Pereira, Liliane Desgualdo
    Mangabeira Albernaz, Pedro Luiz
    Spinola e Castro, Angela M.
    de Lemos, Marisa
    Gushikem, Patricia
    Perez, Ana Paula
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2012, 2 (06) : 216 - 219